Patients infected with human immunodeficiency virus (HIV) often progress to ESRD. In the era of highly active antiretroviral therapy, the care of these patients has become increasingly complex as survival has improved. Patients infected with HIV who also have ESRD are at risk for critical interactions between medication regimens to treat both of these conditions. Within this population, hemo- and peritoneal dialysis as well as kidney transplantation are life sustaining but present a host of obstacles related to HIV monitoring and risk of transmission, access thrombosis, infection, and rejection. Knowledge of antiretroviral regimens, drug interactions, and HIV resistance as well as the management of ESRD in the presence of HIV infection will improve the care of these unique patients.
Division of Nephrology and Hypertension, Department of Internal Medicine, Henry Ford Health System, Detroit, MI; and Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, NC
Address correspondence to James E. Novak, MD, PhD, Henry Ford Health System, CFP-505, 2799 West Grand Boulevard, Detroit, MI 48202.